Urolog. pro Praxi, 2008; 9(6): 287-290
Benefits and disavantages of testosterone supplementation
- 1 Centrum andrologické péče, České Budějovice, Centrum reprodukční medicíny GEST, Praha
- 2 Centrum andrologické péče, České Budějovice
Testosterone supplementation is only indicated in men with well defined underlying testicular disease, pituitary or hypothalamic disease. The treshold for testosterone supplementation for different symptoms and complaints and/or tissue dysfunctions is still poorly defined. This treshold may show interindividual variation. Supraphysiological testosterone supplementation should be avoided, replacement should be physiological. Monitoring of prostatic disease and haematocrit during testosterone therapy is of utmost importance. New treatment modalities should avoid stimulating the prostate, but should maintain the benefits of androgen receptor stimulation in other organs (mood, sexual function, bone). Good communication between physician and patient is very important, expected benefit should be realistic.
Keywords: testosterone supplementation, androgens, old men, expectation
Published: January 1, 2009 Show citation
References
- Behre H. Algorithm for diagnosis and treatment of late-onset hypogonadism - ISA, ISSAM and EAU recommendations. Salzburg: The 5th World Congress oh The Aging Male, 9.-12. 2. 2006.
- Hellstrom JGW. Male Infertility and Sexual Dysfunction. New York: Springer - Verlag, 1997.
Go to original source... - Kawaciuk I. Přínos a rizika androgenní substituce. Andrologie. Praha: 2001.
- Krause W, Rothauge C-F. Andrologie. Stuttgard: Ferdinand Enke Verlag, 1991.
- Kubíček V. Hormonální substituční terapie androgeny. České Budějovice: Newsbulletin ČSSM 1/I, Androboros, 2006.
- KubíčekV. Mužská infertilita a erektilní dysfunkce. Praha: Galén, 1996.
- Kubíček V. Racionální substituční terapie androgeny, Praha: Andrologie, supplementum 2000.
- Kubíček V. Stárnoucí muž - stále nové skutečnosti. Praha: Medical Tribune 2005; 1(1): 7.
- Kubíček V. Terapie androgeny v urologii. edice Endokrinní terapie, Schering AG, 1997.
- Ledda A. Vascular Andrology. Berlin-Heidelberg: Springer Verlag, 1996. Go to original source...
- Moeller, Hoffman. Graging of prostate carcinoma in hypogonadal men (in, ,Late Onset Hypogonadismus", ISSAM Congress, Praha 2004).
- Nieschlag E, Behre HM. Andrology - Male reproductive Health and Dysfunction. Berlin: Springer - Verlag, 1997. Go to original source...
- Nieschlang E., Swedloff R, Behre HM, et al. Investigation, treatment and monitoring of late onset hypogonadism in males. ISA, ISSAM, Torrance, CA, USA 2004. Materiál ISA a ISSAM určený k připomínkám členů.
- TanaghoEA, Aninch, Mac. J. Smith, s General Urology. San Francisco: Lange Medical Book 1995.
- Wagner G, Sarramon JP, Juenemann KP, et al. Erectile Dysfunction and Male Infertility - EAU Teaching Course, Xth Congress of the European Association of Urology, Berlin, July 13-16, 1994.
- Waites GMH, Frick J, Baker GWH, et al. Current Advances in Andrology (Proceedings of the VIth International Congress of Andrology) Salzburg, Austria, May 25 - 29, 1997. Monduzzi Editore, Milano 1997.
- Walsh PC, Retik AB, Stamey TA, Vaughan ED, jr. Campbells Urology. Philadelphia: W. B. Saunders, 1992.